• Home
  • News
  • Fortune 500
    • Fortune Global 500
    • Fortune 500 Europe
    • Fortune China 500
    • Fortune SEA 500
    • Great Place to Work
  • Tech
    • AI
    • Innovation
    • Cybersecurity
  • Finance
    • Personal Finance
    • Real Estate
    • Economy
    • Investing
    • Banking
    • Crypto
  • Leadership
    • Success
    • Future of Work
    • Workplace Culture
    • C-Suite
    • CEO Initiative
  • Lifestyle
    • Arts & Entertainment
    • Travel & Leisure
    • Health
    • Well
    • Education
  • Rankings
    • Analytics
  • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Video
    • Podcasts
  • Home
  • News
  • FORTUNE 500
    • FORTUNE 500
    • FORTUNE SEA 500
    • Fortune 500 Europe
    • Fortune Global 500
    • Fortune China 500
    • Great Place to Work
  • Tech
    • Tech
    • AI
    • Innovation
    • Cybersecurity
  • Finance
    • Finance
    • Personal Finance
    • Real Estate
    • Economy
    • Banking
    • Investing
    • Crypto
  • Leadership
    • Leadership
    • Success
    • Future of Work
    • Workplace Culture
    • C-Suite
    • CEO Initiative
  • Lifestyle
    • Lifestyle
    • Arts & Entertainment
    • Travel & Leisure
    • Health
    • Well
    • Education
  • Rankings
    • Rankings
    • Analytics
  • Multimedia
    • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Video
    • Podcasts
  • Asia
  • Europe
  • Analytics

Sy Mukherjee

Sy Mukherjee is a former health care reporter for Fortune.

    Page 20 of 100

  • Gates Foundation Mastercard Wellcome coronavirusNewsletters

    A powerhouse trio pledges up to $125 million to fight coronavirus

    By Sy Mukherjee
  • Coronavirus Research WorkHealth

    Gates Foundation, Mastercard, and Wellcome team up to fuel coronavirus drug development

    By Sy Mukherjee
  • Coronavirus fake treatmentsNewsletters

    Beware the coronavirus snake oil salesmen

    By Sy Mukherjee
  • CVS Aetna coronavirus testingNewsletters

    CVS will waive out-of-pocket costs related to coronavirus testing and telemedicine visits

    By Sy Mukherjee
  • Coronavirus death rateHealth

    What the rising coronavirus death rate really means

    By Sy Mukherjee
  • CRISPR blindness trialNewsletters

    CRISPR has a milestone moment in treating blindness

    By Sy Mukherjee
  • Coronavirus testNewsletters

    The coronavirus testing conundrum

    By Sy Mukherjee
  • A researcher works in a lab that is developing testing for the COVID-19 coronavirus at Hackensack Meridian Health Center for Discovery and Innovation on February 28, 2020 in Nutley, New Jersey.Health

    Testing for coronavirus should be free, but it’s not always that simple

    By Sy Mukherjee
  • Amazon Alexa medicationsNewsletters

    Amazon’s Alexa can now give you detailed information on your medications

    By Sy Mukherjee
  • George Scangos coronavirus czar biotechNewsletters

    Pharma vet and former Biogen chief to lead biotech industry’s coronavirus response

    By Sy Mukherjee
  • Biogen Sangamo Alzheimers gene therapyNewsletters

    Biogen is doubling down on Alzheimer’s with a massive gene therapy deal

    By Sy Mukherjee
  • Gilead coronavirus trialNewsletters

    Can Gilead tame the coronavirus?

    By Sy Mukherjee
  • Gilead remdesivir clinical trialsHealth

    Gilead’s coronavirus treatment is barreling its way into new clinical trials

    By Sy Mukherjee
  • Apple J&J heart studyNewsletters

    Apple and Johnson & Johnson team up on heart study

    By Sy Mukherjee
  • COVID-19-Coronavirus-microscopeHealth

    The first U.S. trial for a coronavirus treatment has started

    By Sy Mukherjee
    Rankings
    • 100 Best Companies
    • Fortune 500
    • Global 500
    • Fortune 500 Europe
    • Most Powerful Women
    • Future 50
    • World’s Most Admired Companies
    • See All Rankings
    Sections
    • Finance
    • Leadership
    • Success
    • Tech
    • Asia
    • Europe
    • Environment
    • Fortune Crypto
    • Health
    • Retail
    • Lifestyle
    • Politics
    • Newsletters
    • Magazine
    • Features
    • Commentary
    • MPW
    • CEO Initiative
    • Conferences
    • Personal Finance
    • Education
    Customer Support
    • Frequently Asked Questions
    • Customer Service Portal
    • Privacy Policy
    • Terms of Use
    • Single Issues for Purchase
    • International Print
    Commercial Services
    • Advertising
    • Fortune Brand Studio
    • Fortune Analytics
    • Fortune Conferences
    • Business Development
    About Us
    • About Us
    • Editorial Calendar
    • Press Center
    • Work at Fortune
    • Diversity and Inclusion
    • Terms and Conditions
    • Site Map

    © 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.